SSBP2 and esophageal squamous cell carcinoma: Most studies have suggested a tumor suppressive role of SSBP2, which is silenced by promoter hypermethylation in several human tumors, including hematologic malignancies, prostate cancer, esophageal squamous cell carcinoma, ovarian cancer, and gallbladder cancer [5–9].